|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
104.63(B) |
Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
9 |
19 |
36 |
69 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-27 |
4 |
D |
$7.33 |
$20,934 |
D/D |
(2,856) |
78,508 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,758 |
81,364 |
|
- |
|
Bose Supratim |
EVP & President, Asia-Pacific |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,184 |
18,109 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-27 |
4 |
D |
$7.33 |
$7,843 |
D/D |
(1,070) |
107,981 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,184 |
109,051 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-02-27 |
4 |
D |
$7.33 |
$43,760 |
D/D |
(5,970) |
177,154 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,312 |
183,124 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-27 |
4 |
D |
$7.33 |
$19,139 |
D/D |
(2,611) |
84,192 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,961 |
86,803 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-27 |
4 |
D |
$7.33 |
$16,683 |
D/D |
(2,276) |
23,091 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,165 |
25,367 |
|
- |
|
Mahoney Michael F |
President & CEO |
|
2013-02-27 |
4 |
D |
$7.33 |
$136,734 |
D/D |
(18,654) |
294,029 |
|
- |
|
Mahoney Michael F |
President & CEO |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,324 |
312,683 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-27 |
4 |
D |
$7.33 |
$17,130 |
D/D |
(2,337) |
74,852 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
77,189 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-27 |
4 |
D |
$7.33 |
$5,886 |
D/D |
(803) |
71,116 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,388 |
71,919 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-27 |
4 |
D |
$7.33 |
$28,367 |
D/D |
(3,870) |
68,989 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,961 |
72,859 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2013-02-27 |
4 |
D |
$7.33 |
$33,344 |
D/D |
(4,549) |
125,680 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,535 |
130,229 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-27 |
4 |
D |
$7.33 |
$32,347 |
D/D |
(4,413) |
122,146 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,535 |
126,559 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-27 |
4 |
D |
$7.33 |
$24,570 |
D/D |
(3,352) |
76,165 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,350 |
79,517 |
|
- |
|
1831 Records found
|
|
Page 12 of 74 |
|
|